Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Go back to Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
(NASDAQ: MIRM) Delayed: 80.39 --0 (-0%)
Previous Close $80.39    52 Week High $ 
Open $80.39    52 Week Low $ 
Day High $80.39    P/E N/A 
Day Low $80.39    EPS $ 
Volume 49